Bryan Wahl Tarsus Pharmaceuticals, Inc. (TARS) insider trading activity
Bryan Wahl is General Counsel of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 51,712 shares of TARS, which is worth approximately $2.68 Million. The most recent transaction as insider was on Mar 20, 2025, when has been sold 3,084 shares (Common Stock) at a price of $50.11 per share, resulting in proceeds of $154,539. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
51.7K
26.28%
3M change
26.28%
12M change
Total Value Held
$2.68 Million
Bryan Wahl Transaction History
BW
Bryan Wahl
General Counsel
Irvine, CA